AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York



    QUEBEC CITY, Sept. 20 /CNW Telbec/ - AEterna Zentaris Inc. (TSX: AEZ;
Nasdaq:   AEZS), a global biopharmaceutical company focused on endocrine therapy
and oncology, today announced that its President and CEO, David J. Mazzo,
Ph.D., will present a Company overview at the UBS Global Life Sciences
Conference on Thursday, September 27, 2007 at 10:00 a.m. Eastern, in the
Ballroom E of the Grand Hyatt Hotel in New York City.
    A live webcast of this presentation will be available on AEterna
Zentaris' website at www.aeternazentaris.com in the Investors section. A
replay will also be available for a period of 30 days on the Company's
website.

    About AEterna Zentaris Inc.

    AEterna Zentaris Inc. is global biopharmaceutical company focused on
endocrine therapy and oncology with proven expertise in drug discovery,
development and commercialization.
    News releases and additional information are available at
www.aeternazentaris.com.




For further information:

For further information: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (908) 938-1475,
jenene.thomas@aeternazentaris.com; Paul Burroughs, Media Relations, (418)
652-8525 ext. 406, paul.burroughs@aeternazentaris.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890